Vivid
Payments companies reported to CMS as associated with Vivid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Vivid, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Vivid
These are the largest totals companies reported as associated with Vivid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Christos Mihos | Miami Beach, FL | Cardiovascular Disease | $23,265.00 |
| Akhil Narang | Chicago, IL | Cardiovascular Disease | $20,298.72 |
| Karl Schwarz | Rochester, NY | Cardiovascular Disease | $15,000.00 |
| Pei Ni Jone | Chicago, IL | Pediatric Cardiology | $6,600.00 |
| Sanket Shah | Kansas City, MO | Pediatric Cardiology | $5,819.00 |
| Paul Sorajja | Phoenix, AZ | Interventional Cardiology | $4,522.00 |
| Jordan Strom | Boston, MA | Cardiovascular Disease | $3,250.00 |
| Gerard Aurigemma | Worcester, MA | Cardiovascular Disease | $2,400.00 |
| Jyothy Puthumana | Chicago, IL | Cardiovascular Disease | $2,400.00 |
| Javier Gomez-Valencia | Chicago, IL | Cardiovascular Disease | $2,400.00 |
Prescribed Vivid?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.